New bloodthinners thicken the drug market

Published November 24, 2010

New bloodthinners thicken the drug market
For decades, doctors have tended to rely on one very imperfect drug for patients who need to take a blood thinner to prevent clots from forming and traveling to their heart, lungs, legs or brain.
Read more on Washington Post

Vertex submits NDA application for telaprevir to treat hepatitis C
Vertex Pharmaceuticals Incorporated announced today that it has completed the submission of a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) seeking approval for telaprevir, Vertex’s investigational treatment for people with hepatitis C.
Read more on News-Medical-Net

Vt. law on drug data mining ruled unconstitutional
A Vermont law that restricts companies’ use of information about the drugs doctors prescribe is unconstitutional on free speech grounds, a federal appeals court ruled Tuesday.
Read more on AP via Yahoo! Finance